The global impact of Precision Medicine Group.
As it happens.

Impact, observations, and insights on the evolving healthcare landscape.

Precision for Medicine Acquires EganLee, Expands Foothold in the Asia-Pacific (APAC) market


We are excited to announce that EganLee, an Australian-based firm providing a range of clinical trial services for the pharmaceutical, biotechnology, medical device and CRO industries has joined the Precision family! With strong, established relationships with numerous AsiaPac research sites, the acquisition of EganLee expands Precision’s clinical trial footprint in AsiaPac.


Precision Value & Health Acquires Global Omnichannel Engagement Leader, Across Health

2021-03-23T23:23:57-04:00News, Press Releases|

EU-based team brings a unique omnichannel optimization platform and digital transformation capabilities to leading life-sciences companies

BETHESDA, MDMarch 24, 2021—Precision Value & Health, the industry leader for commercialization services for innovative life science companies, today announced that it has acquired Across Health. Across Health is a leading global omnichannel engagement consultancy focused on providing clients an analytical and evidence-based framework for commercial strategy, execution, and resource optimization. The company’s solutions are based around its proprietary, market-leading Navigator365 product suite, which more than 40 pharmaceutical companies rely on for omnichannel planning and resource allocation. The Across Health team is already working hand-in-hand with Precision’s medical communications, creative, and data sciences teams to offer analytically driven launch and commercialization programs across the product life cycle.


MM&M Hall of Femme 2019 Honors Carolyn Morgan


We are excited to share that Carolyn Morgan, president of Precisioneffect, will be inducted into the MM&M Hall of Femme. This program honors honor standout U.S. healthcare commercial executives who have made a significant impact on their organization’s success in the past year. 


Precision for Medicine Acquires Industry-leading Artificial Intelligence Technology, Significantly Expands Cloud-based Multiomic Data Integration and Informatics Platform QuartzBio™

2020-07-23T16:13:47-04:00News, Press Releases|


Bethesda, MD – March 6, 2019 – Precision for Medicine, part of Precision Medicine Group, today announced the acquisition of SimplicityBio, adding artificial intelligence to Precision’s QuartzBio™ multiomic data integration and informatics platform. The addition of an artificial intelligence engine to QuartzBio provides Precision’s clients the most robust, sophisticated end-to-end solution for the “big data” challenge observed in biomarker-guided drug development—furthering their mission of maximizing the value and utility of biomarker data generated in the course of a clinical trial.


New FDA HCEI and PIE Guidelines Released: Are You Prepared? Sign up for our Free, Live Webinar Today!

2020-07-23T16:17:10-04:00Events, News|

On Wednesday, September 26th at 10:00am PDT/1:00pm EDT please join us for a special, live webinar:

Navigating the FDA’s Final Guidance on HCEI and PIE:
Value Communication That Works 

Presented by:

Ross Maclean, MD, PhD
Vice President,
Head of Medical Affairs
Ami Gopalan, PharmD, MBA
Vice President, Director,
Payer Access Solutions


Precision Value & Health Listed in MM&Ms Top 100 Agencies


We are excited to announce that Precision Value & Health, a business unit of Precision Medicine Group, has been ranked #6 in MM&M magazine’s Agency Top 100 list! With a 10.6% increase in revenue from the previous year, they are continuing to add talent and services–partnering with pharmaceutical and life sciences companies to ensure patient access to life-changing therapies. (more…)

Load More Posts